Works matching IS 00070920 AND DT 2011 AND VI 104 AND IP 8

Results: 19

Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis.

Published in:

2011

By:

Duiker, E. W.;
Meijer, A.;
van der Bilt, A. R. M.;
Meersma, G. J.;
Kooi, N.;
van der Zee, A. G. J.;
de Vries, E. G.;
de Jong, S.

Publication type:

journal article

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.

Published in:

2011

By:

Chua, W.;
Charles, K. A.;
Baracos, V. E.;
Clarke, S. J.

Publication type:

journal article

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2.

Published in:

2011

By:

Osorio, A.;
Milne, R. L.;
Alonso, R.;
Pita, G.;
Peterlongo, P.;
Teulé, A.;
Nathanson, K. L.;
Domchek, S. M.;
Rebbeck, T.;
Lasa, A.;
Konstantopoulou, I.;
Hogervorst, F. B.;
Verhoef, S.;
van Dooren, M. F.;
Jager, A.;
Ausems, M. G. E. M.;
Aalfs, C. M.;
van Asperen, C. J.;
Vreeswijk, M.;
Waisfisz, Q.

Publication type:

journal article

Detection of HER2 amplification in circulating free DNA in patients with breast cancer.

Published in:

2011

By:

Page, K.;
Hava, N.;
Ward, B.;
Brown, J.;
Guttery, D. S.;
Ruangpratheep, C.;
Blighe, K.;
Sharma, A.;
Walker, R. A.;
Coombes, R. C.;
Shaw, J. A.

Publication type:

journal article

Inhibin/activin expression in human and rodent liver: subunits α and βB as new players in human hepatocellular carcinoma?

Published in:

2011

By:

Frost, K.;
Seir, K.;
Lackner, A.;
Grusch, M.;
Grasl-Kraupp, B.;
Schulte-Hermann, R.;
Rodgarkia-Dara, C.

Publication type:

journal article

Markers for the non-invasive diagnosis of mesothelioma: a systematic review.

Published in:

2011

By:

Van der Bij, S.;
Schaake, E.;
Koffijberg, H.;
Burgers, J. A.;
de Mol, B. A. J. M.;
Moons, K. G. M.

Publication type:

journal article

Reply: Is Epstein-Barr virus associated with aggressive forms of breast cancer?

Published in:

2011

By:

Mazouni, C.;
Fina, F.;
Martin, P.-M.

Publication type:

Letter

Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas.

Published in:

2011

By:

Handra-Luca, A.;
Hong, S.-M.;
Walter, K.;
Wolfgang, C.;
Hruban, R.;
Goggins, M.

Publication type:

journal article

Is Epstein-Barr virus associated with aggressive forms of breast cancer?

Published in:

2011

By:

Khan, G.;
Philip, P. S.;
Al Ashari, M.

Publication type:

commentary

Impact of multidisciplinary team management in head and neck cancer patients.

Published in:

2011

By:

Friedland, P. L.;
Bozic, B.;
Dewar, J.;
Kuan, R.;
Meyer, C.;
Phillips, M.

Publication type:

journal article

Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration.

Published in:

2011

By:

Fan, F.;
Samuel, S.;
Gaur, P.;
Lu, J.;
Dallas, N. A.;
Xia, L.;
Bose, D.;
Ramachandran, V.;
Ellis, L. M.

Publication type:

journal article

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial.

Published in:

2011

By:

Procopio, G.;
Verzoni, E.;
Bracarda, S.;
Ricci, S.;
Sacco, C.;
Ridolfi, L.;
Porta, C.;
Miceli, R.;
Zilembo, N.;
Bajetta, E.

Publication type:

journal article

High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients.

Published in:

2011

By:

Reuschenbach, M.;
Tran, T.;
Faulstich, F.;
Hartschuh, W.;
Vinokurova, S.;
Kloor, M.;
Krautkrämer, E.;
Zeier, M.;
Von Knebel Doeberitz, M.;
Sommerer, C.;
Krautkrämer, E

Publication type:

journal article

Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer.

Published in:

2011

By:

Loupakis, F.;
Cremolini, C.;
Fioravanti, A.;
Orlandi, P.;
Salvatore, L.;
Masi, G.;
Di Desidero, T.;
Canu, B.;
Schirripa, M.;
Frumento, P.;
Di Paolo, A.;
Danesi, R.;
Falcone, A.;
Bocci, G.

Publication type:

journal article

Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility.

Published in:

2011

By:

Challen, C.;
Brown, H.;
Cai, C.;
Betts, G.;
Paterson, I.;
Sloan, P.;
West, C.;
Birch-Machin, M.;
Robinson, M.

Publication type:

journal article

Social support, gender and patient delay.

Published in:

2011

By:

Pedersen, A. F.;
Olesen, F.;
Hansen, R. P.;
Zachariae, R.;
Vedsted, P.

Publication type:

journal article

CpG-island methylation study of liver fluke-related cholangiocarcinoma.

Published in:

2011

By:

Sriraksa, R.;
Zeller, C.;
El-Bahrawy, M. A.;
Dai, W.;
Daduang, J.;
Jearanaikoon, P.;
Chau-in, S.;
Brown, R.;
Limpaiboon, T.

Publication type:

journal article

The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer.

Published in:

2011

By:

Sheng, Q.;
Liu, J.

Publication type:

journal article

Multifunctional transcription factor TFII-I is an activator of BRCA1 function.

Published in:

2011

By:

Tanikawa, M.;
Wada-Hiraike, O.;
Nakagawa, S.;
Shirane, A.;
Hiraike, H.;
Koyama, S.;
Miyamoto, Y.;
Sone, K.;
Tsuruga, T.;
Nagasaka, K.;
Matsumoto, Y.;
Ikeda, Y.;
Shoji, K.;
Oda, K.;
Fukuhara, H.;
Nakagawa, K.;
Kato, S.;
Yano, T.;
Taketani, Y.

Publication type:

journal article